You are here

Brilinta

PhaseBio’s Reversal Agent for Astra’s Brilinta could Spell Success for Both

BioSpace

Thu, 06/23/22 - 10:32 am

antiplatelet therapy

AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup

Pharma Times

Wed, 11/18/20 - 11:03 pm

clinical trials

Go or no go? Vaccine panel upstages US approval decisions

EP Vantage

Fri, 10/2/20 - 12:44 pm

Kala Pharmaceuticals

dry eye disease

AstraZeneca puts COVID-19 spin on heart disease awareness, Brilinta campaigns

Fierce Pharma

Wed, 09/9/20 - 10:36 am

celebrity endorsements

AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients

Fierce Pharma

Thu, 07/16/20 - 11:24 pm

clinical trials

Full Brilinta study results show the blood thinner reduces rate of secondary stroke

Endpoints

Thu, 07/16/20 - 10:40 am

clinical trials

AZ claims FDA okay for Brilinta in coronary artery disease patients

Pharmaforum

Tue, 06/2/20 - 10:48 am

coronary artery disease

AstraZeneca makes case for use of blood thinner Brilinta in stroke patients

Endpoints

Mon, 01/27/20 - 10:40 am

clinical trials

AHA: AstraZeneca's Brilinta linked to less bleeding solo than as an aspirin add-on

Fierce Pharma

Sun, 11/17/19 - 08:35 pm

PhaseBio touts 'breakthrough' badge for bloodthinner reversal agent licensed from AstraZeneca, shares leap

Endpoints

Tue, 04/9/19 - 08:22 am

bloodthinner reversals

breakthrough status

AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study

Endpoints

Mon, 02/25/19 - 09:50 am

clinical trials

AstraZeneca and UPMC Health Plan Form Unique Outcome Based Agreement

CP Wire

Mon, 01/28/19 - 12:52 pm

outcomes-based contracts

AstraZeneca executives try to shift I-O focus with China, Brilinta wins

Fierce Pharma

Fri, 11/10/17 - 09:35 am

immuno-oncology

With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC

Fierce Pharma

Thu, 08/24/17 - 11:25 am

AstraZeneca Expects Brilinta to Become a Blockbuster Therapy in 2017

Market Realist

Wed, 07/12/17 - 10:01 am

Here's Why AstraZeneca Dipped 14.2% in October

Motley Fool

Thu, 11/10/16 - 10:22 am

AstraZeneca: Despite Brilinta's Trial Miss, Long-Term Holds Potential

Seeking Alpha

Wed, 10/12/16 - 11:16 am

AstraZeneca's Brilinta Didn't Meet Primary Endpoint

Yahoo/Benzinga

Tue, 10/4/16 - 10:12 pm

peripheral artery disease

clinical trials

Takeda renames antidepressant after name confusion leads to errors

BioPharma Dive

Tue, 05/3/16 - 09:49 pm

antidepressants

What AstraZeneca Heart Drug Failure Means

Bidness, ETC

Fri, 03/25/16 - 09:32 am

Pages